Emergent Biosolutions Inc Live Stock Price Today, Share Analysis and Chart

Name: Emergent Biosolutions Inc: Is Infosys Ltd. worth buying?
Item: Emergent Biosolutions Inc
Rating: 1.738152875
Author: Trendlyne DVM scores

Await Turnaround

about

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal S...

8.21 -0.12 (-1.44%)

41.61% Fall from 52W High

598.6K

XNYS Volume

XNYS 14 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Emergent Biosolutions Inc is on 22 May 2026 for the purpose of Emergent BioSolutions Inc Annual General Meeting for 2026 See details

Low Financial Strength

27.8 / 100

Mid Valuation

45.7 / 100

Technically Neutral

37.8 / 100

Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM

1Yr Price target upside is 46%

2 analysts

Emergent Biosolutions Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Emergent Biosolutions Inc Live Stock Price Today, Share Analysis and Chart

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal S...

41.61% Fall from 52W High

SWOT Analysis

Emergent Biosolutions Inc Live Price Chart